Anika Therapeutics Ratios (2010-2026) | ANIK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	54.56%	58.23%	50.62%	59.42%	62.69%	56.57%	-135.45%	60.23%	65.40%	60.16%	-199.14%	65.38%	66.69%	65.66%	55.96%	56.10%	50.90%	56.02%	62.65%	64.15%
EBT Margin (Quarter)	23.93%	3.17%	-39.43%	-10.11%	-8.28%	-13.32%	-455.29%	-31.68%	-6.93%	-16.98%	-871.99%	-6.59%	-3.95%	1.10%	-4.17%	-14.79%	-14.05%	-8.04%	35.97%	-16.28%
EBIT Margin (Quarter)	24.07%	3.29%	-25.47%	-9.69%	-8.53%	-14.40%	-588.55%	-33.10%	-8.20%	-18.51%	-852.09%	-8.63%	-5.89%	-0.27%	-2.30%	-16.37%	-14.81%	-11.62%	2.11%	-18.53%
EBITDA Margin (Quarter)	17.64%	1.91%	-17.29%	-8.21%	-9.30%	-12.48%	138.28%	-26.57%	-6.16%	-16.84%	2,151.74%	-16.84%	-0.62%	-98.80%	-74.99%	-16.02%	-9.29%	-9.03%	0.89%	-18.26%
Operating Margin (Quarter)	24.07%	3.29%	-25.47%	-9.69%	-8.53%	-14.40%	-588.55%	-33.10%	-8.20%	-18.51%	-852.09%	-8.63%	-5.89%	-0.27%	-2.30%	-16.37%	-14.81%	-11.62%	2.11%	-18.53%
Net Margin (Quarter)	17.12%	1.41%	-30.01%	-7.99%	-7.17%	-10.34%	-218.16%	-27.29%	-6.25%	-15.77%	-589.86%	-8.81%	7.98%	-94.97%	-63.33%	-3.50%	2.40%	3.04%	-4.93%
FCF Margin (Quarter)	5.59%	11.57%	13.06%	-8.71%	2.89%	2.53%	-191.25%	-13.20%	-15.72%	7.13%	-221.11%	-2.58%	-18.42%	12.86%	24.08%	-2.42%	-14.10%	39.99%	13.09%	-16.55%
Efficiency
Inventory Average (Quarter)	42.79M	38.94M	35.51M	35.62M	35.28M	36.29M	38.50M	40.54M	41.96M	43.16M	34.08M	36.92M	50.44M	45.55M	31.72M	22.57M	19.13M	16.60M	17.54M	20.81M
Assets Average (Quarter)	362.69M	358.03M	350.23M	344.89M	348.18M	350.93M	348.44M	344.10M	333.98M	328.52M	299.39M	267.19M	263.20M	247.03M	217.07M	196.67M	189.14M	188.56M	189.85M	184.83M
Equity Average (Quarter)	281.73M	288.43M	288.57M	286.44M	285.97M	285.55M	285.25M	281.58M	275.80M	272.25M	241.38M	210.40M	209.44M	195.10M	166.93M	151.19M	148.03M	147.24M	145.13M	138.68M
Invested Capital (Quarter)	303.67M	294.36M	291.40M	290.09M	290.47M	284.94M	285.56M	277.59M	274.01M	270.49M	212.26M	208.54M	210.34M	179.86M	153.99M	148.40M	147.67M	146.81M	143.47M	133.90M
Asset Utilization Ratio (Quarter)	0.38	0.40	0.42	0.44	0.44	0.43	0.33	0.33	0.36	0.37	0.40	0.42	0.37	0.35	0.55	0.60	0.61	0.60	0.59	0.63
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)	0.06	0.01	0.02	0.02	0.02
Debt Ratio (Quarter)	0.05	0.01	0.01	0.01	0.01
Equity Ratio (Quarter)	0.79	0.82	0.83	0.84	0.81	0.82	0.82	0.82	0.83	0.82	0.78	0.79	0.80	0.78	0.76	0.78	0.79	0.77	0.75	0.75
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-97.18M	-90.98M	-124.23M	-119.64M	-123.56M	-121.94M	-120.95M	-110.37M	-101.81M	-105.33M	-95.10M	-100.71M	-96.59M	-90.72M	-79.22M	-75.36M	-77.12M	-80.18M	-81.17M	-66.79M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.02%	0.00%	0.00%	0.00%	-0.06%	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-4.81%	-1.89%	0.82%	-0.69%	-4.63%	-6.73%	1.15%	-1.69%	-1.80%	-2.48%	0.31%	4.56%	5.36%	9.17%	-2.63%	-3.85%	-5.34%	-7.32%	-6.58%	-7.48%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.06%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Anika Therapeutics Ratios (2010-2026) | ANIK

Create an account

Sign In

Reset Password